TickerGuard
Buy Day today: Neutral (47) Mixed market breadth · no major macro event
INKT

Mink Therapeutics Inc

Healthcare · Biotechnology

11.40$ -2.4% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow INKT
Line item 2019 2020 2021 2022 2023 2024 2025
– – – – – – –
– +49.6% +41.6% +56.2% +68.1% +5.3% -15.6%
– -60.0% +1,886.5% +73.5% +27.5% -53.1% +47.7%
– +400.6% +113.1% -77.7% – – –
– -107.9% – +134.6% -67.0% -84.1% +615.4%
– -77.7% +161.5% +0.4% -70.6% -100.0% -100.0%
– -77.7% +161.5% +0.4% -70.6% – –
– – – – +203.9% -100.0% –
– -2.9% -14.8% -100.0% – – -100.0%
– -2.9% +343.5% -100.3% +161.7% – +36.1%
– – +1,413.2% -153.2% – – +626.0%
– – – – – – –

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?